Men with organ-confined prostate cancer and positive surgical margins develop biochemical failure at a similar rate to men with extracapsular extension

Urology

Volumn 78, Issue 1, 2011, Pages 121-125

  Psutka, Sarah P ^a   Feldman, Adam S ^a   Rodin, David ^a   Olumi, Aria F ^a   Wu, Chin Lee ^a   McDougal, W Scott ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BIOCHEMICAL FAILURE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; GLEASON SCORE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; POSITIVE SURGICAL MARGIN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CANCER; RADICAL RETROPUBIC PROSTATECTOMY; TUMOR VOLUME;

COHORT STUDIES; HUMANS; MALE; NEOPLASM INVASIVENESS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 79959703933     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.10.036     Document Type: Article

References (21)

1. A.W. Partin, M.W. Kattan, and E.N. Subong Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update JAMA 277 1997 1445 1451 (Pubitemid 27208886)
2. T.A. Stamey, J.E. McNeal, and C.M. Yemoto Biological determinants of cancer progression in men with prostate cancer JAMA 281 1999 1395 1400 (Pubitemid 29190217)
3. M.W. Kattan, J.A. Eastham, and A.M. Stapleton A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer J Natl Cancer Inst 90 1998 766 771 (Pubitemid 28259189)
4. P. Swindle, J.A. Eastham, and M. Ohori Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens J Urol 174 2005 903 907 (Pubitemid 41140626)
5. A.J. Stephenson, D.P. Wood, and M.W. Kattan Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy J Urol 182 2009 1357 1363
6. J. Pfitzenmaier, S. Pahernik, and T. Tremmel Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression? BJU Int 102 2008 1413 1418
7. S.S. Chang, and M.S. Cookson Impact of positive surgical margins after radical prostatectomy Urology 68 2006 249 252 (Pubitemid 44175518)
8. R.E. Emerson, M.O. Koch, and T.D. Jones The influence of extent of surgical margin positivity on prostate specific antigen recurrence J Clin Pathol 58 2005 1028 1032 (Pubitemid 41416050)
9. M.A. Simon, S. Kim, and M.S. Soloway Prostate specific antigen recurrence rates are low after radical retropubic prostatectomy and positive margins J Urol 175 2006 140 144 (Pubitemid 41797113)
10. T. Fesseha, W. Sakr, and D. Grignon Prognostic implications of a positive apical margin in radical prostatectomy specimens J Urol 158 1997 2176 2179 (Pubitemid 27481352)
11. G.D. Grossfeld, J.J. Chang, and J.M. Broering Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database J Urol 163 2000 1171 1177 (Pubitemid 30169385)
12. A.N. Vis, F.H. Schroder, and T.H. van der Kwast The actual value of the surgical margin status as a predictor of disease progression in men with early prostate cancer Eur Urol 50 2006 258 265 (Pubitemid 44038060)
13. A.B. Jani, and J. Kao Postprostatectomy adjuvant versus salvage radiotherapy: a complication-adjusted number-needed-to-treat analysis Cancer 103 2005 1833 1842 (Pubitemid 40563255)
14. J.F. Ward, J.M. Slezak, and M.L. Blute Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome BJU Int 95 2005 751 756 (Pubitemid 40547200)
15. S.J. Freedland, W. Aronson, and J.C. Presti Jr Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3? Results from the SEARCH database J Urol 169 2003 2142 2146 (Pubitemid 36576735)
16. S. Shikanov, J. Song, and C. Royce Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence J Urol 182 2009 139 144
17. T.H. Van der Kwast, M. Bolla, and H. Van Poppel Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911 J Clin Oncol 25 2007 4178 4186 (Pubitemid 47548556)
18. I.M. Thompson, C.M. Tangen, and J. Paradelo Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial J Urol 181 2009 956 962
19. T. Wiegel, D. Bottke, and U. Steiner Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95 J Clin Oncol 27 2009 2924 2930
20. J.E. Johansson, O. Andren, and S.O. Andersson Natural history of early, localized prostate cancer JAMA 291 2004 2713 2719 (Pubitemid 38725420)
21. C.R. Pound, A.W. Partin, and M.A. Eisenberger Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597 (Pubitemid 29211767)